MedTrace Logo

The Jinling Cohort

NCT06011694 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2023-08-25

No results posted yet for this study

Summary

The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.

Conditions

  • Cancer
  • Multi Cancer Early Screening
  • Liquid Biopsy

Interventions

OTHER

MERCURY test, health questionnaires and annual routine physical exams

Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.

Sponsors & Collaborators

  • Nanjing Shihejiyin Technology, Inc.

    lead INDUSTRY

Principal Investigators

  • Shao Yang, Ph.D · NanjingShihejiyin Technology Inc.

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2027-05-15
Completion
2027-05-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06011694 on ClinicalTrials.gov